Endogenous anti-β-glucan antibodies, a potential predictive biomarker for the efficacy of soluble yeast β-1,3/1,6 glucan (Imprime PGG®) immunotherapy in cancer patients (VAC3P.947)
Antonysamy, Mary, Bose, Nandita, Chan, Anissa, Ertelt, Katie, Gorden, Keith, Grossman, William, Huhn, Richard, Jonas, Adria, Leonardo, Steven, Lowe, Jamie, Mattson, Paulette, McMurray, Diane, Nelson, Mariana, Ottoson, Nadine, Patchen, Myra, Qiu, Xiaohong, Rathman, Blaine, Walsh, Richard, Wurst, Lindsay, Yokoyama, Yumi
Published in The Journal of immunology (1950) (01.05.2014)
Published in The Journal of immunology (1950) (01.05.2014)
Get full text
Journal Article